Chemical Enhancement of In Vitro and In Vivo Direct Cardiac Reprogramming

Abstract

Transforming growth factor-β and WNT inhibitors jointly enhance GMT-induced direct cardiac reprogramming from cardiac fibroblasts in vitro and in vivo and provide a more robust platform for cardiac regeneration.